Creador, White Oak and Siguler Guff completed the acquisition of a majority stake in La Renon.

Creador, a private equity firm, White Oak, a boutique investment management firm, and Siguler Guff, a multi-strategy private equity investment firm, completed the acquisition of a majority stake in La Renon, pharmaceutical company, focusing on chronic disease management across various segments. Financial terms were not disclosed.